zenocutuzumab-zbco

zenocutuzumab-zbco (BIZENGRI) is an FDA-listed pharmaceutical active ingredient. Route of administration: solution. Current US regulatory status: approved.

BIZENGRI is a marketed brand name for zenocutuzumab-zbco. Check FDA Drugs@FDA for the current US label holder and prescribing information.

zenocutuzumab-zbco has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.